‘No time like the present’ for Queensland RSV vaccine rollout The college is urging the state to follow Western Australia’s lead with a ‘lifesaving’ immunisation program.
RSV vaccine could ‘change the landscape’ of hospital presentations Western Australia’s $11 million statewide immunisation rollout follows extensive RACGP advocacy around the issue.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
New chronic cough advice ‘well worth bookmarking’ A ‘comprehensive’ update to chronic cough advice suggests child‐specific management will improve clinical outcomes.
Ventolin nebules shortage flagged A shortage of the 2.5 mg/2.5 mL salbutamol inhalation solution ampoule is expected from mid next week until August 2024.
Nurse-led clinics ‘another slap in the face’ The RACGP has strongly criticised the establishment of five new urgent care clinics in the ACT, saying they contradict Federal guidance.
Future asthma risk flagged for babies with food allergy Even if the allergy is outgrown, poorer lung function outcomes are more likely by six years of age, a world-first study finds.
First RSV vaccine approved in US The US drugs regulator has given the green light to a new vaccine, which is also under consideration by the TGA in Australia.
Possible RSV vaccine is ‘very exciting’ Given to pregnant women, the RSV vaccine is shown to prevent severe disease for up to the first six months of life.
Government expands GP-led endometriosis clinic plan There are now plans for 20 clinics based around the country which will target endometriosis and pelvic pain.